KN
Keay Nakae Chardan Capital Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
75
Avg Return
Past Year
Past Year
12%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
77.8%
Neutral
22.2%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Health Information Services
Medical Care Facilities
Medical Devices
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $60 |
8%
downside
| 2 | +29% |
0
%
| 1 Dec ‘25 3 days ago |
|
|
|
Neutral
Maintained
| $2.50 |
49%
upside
| 1 | – |
–
| 20 Nov ‘25 14 days ago |
|
|
|
Buy
Maintained
| $12 |
214%
upside
| 2 | +14% |
0
%
| 17 Nov ‘25 17 days ago |
|
|
|
Buy
Maintained
| $5 |
15%
upside
| 1 | +11% |
0
%
| 14 Nov ‘25 20 days ago |
|
|
|
Buy
Maintained
| $14 |
133%
upside
| 2 | -1% |
0
%
| 14 Nov ‘25 20 days ago |
|
|
|
Buy
Maintained
| $100 |
30%
upside
| 4 | +17% |
0
%
| 13 Nov ‘25 21 days ago |
|
|
|
Buy
Maintained
| $20 |
329%
upside
| 1 | +5% |
0
%
| 13 Nov ‘25 21 days ago |
|
|
|
Neutral
Downgraded
| $7 |
2%
upside
| 1 | +39% |
0
%
| 13 Nov ‘25 21 days ago |
|
|
|
Neutral
Maintained
| $72 |
1%
upside
| 3 | +15% |
0
%
| 11 Nov ‘25 23 days ago |
|
|
|
Buy
Maintained
| $4 |
90%
upside
| 1 | -5.8% |
0
%
| 4 Nov ‘25 1 month ago |
|